These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 9371603

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Identification of peplomer cleavage site mutations arising during persistence of MHV-A59.
    Gombold JL, Hingley ST, Weiss SR.
    Adv Exp Med Biol; 1993; 342():157-63. PubMed ID: 8209723
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. The effect of the T1087N S gene mutation on MHV-A59 pathogenesis.
    Das Sarma J, Fu L, Lavi E.
    Adv Exp Med Biol; 2001; 494():155-7. PubMed ID: 11774461
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Selection in persistently infected murine cells of an MHV-A59 variant with extended host range.
    Schickli JH, Wentworth DE, Zelus BD, Holmes KV, Sawicki SG.
    Adv Exp Med Biol; 1998; 440():735-41. PubMed ID: 9782352
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.
    Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, Weiss SR.
    J Virol; 2006 Jun; 80(12):5768-76. PubMed ID: 16731916
    [Abstract] [Full Text] [Related]

  • 69. The C12 mutant of MHV-A59 is very weakly demyelinating and has five amino acid substitutions restricted to the spike and replicase genes.
    Leparc-Goffart I, Hingley ST, Jiang X, Chua MM, Lavi E, Weiss SR.
    Adv Exp Med Biol; 1998 Jun; 440():627-33. PubMed ID: 9782338
    [Abstract] [Full Text] [Related]

  • 70. The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus.
    Bos EC, Luytjes W, van der Meulen HV, Koerten HK, Spaan WJ.
    Virology; 1996 Apr 01; 218(1):52-60. PubMed ID: 8615041
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Primary structures of hemagglutinin-esterase and spike glycoproteins of murine coronavirus DVIM.
    Morita E, Ebina H, Muto A, Himeno H, Hatakeyama K, Sugiyama K.
    Virus Genes; 1998 Apr 01; 17(2):123-8. PubMed ID: 9857985
    [Abstract] [Full Text] [Related]

  • 75. Mutational analysis of fusion peptide-like regions in the mouse hepatitis virus strain A59 spike protein.
    Luo ZL, Weiss SR.
    Adv Exp Med Biol; 1998 Apr 01; 440():17-23. PubMed ID: 9782260
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Receptor-induced conformational changes of murine coronavirus spike protein.
    Matsuyama S, Taguchi F.
    J Virol; 2002 Dec 01; 76(23):11819-26. PubMed ID: 12414924
    [Abstract] [Full Text] [Related]

  • 80. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV.
    Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV, Dieffenbach CW.
    J Virol; 1991 Dec 01; 65(12):6881-91. PubMed ID: 1719235
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.